Human monkeypox was first identified in 1970 in the Democratic Republic of
the Congo. Extensive studies of this zoonotic infection in the 1970s and 19
80s indicated a largely sporadic disease with a minority of cases resulting
from person-to-person transmission, rarely beyond two generations. In Augu
st 1996, an unusually large outbreak of human monkeypox was reported, and c
ases continued through 1997 with peak incidence in August 1996, March 1997
and August 1997. Preliminary results from the field investigations in 1997
suggest a new epidemiological pattern where a majority of secondary cases r
esult from person-to-person transmission, and a clinically milder disease.
Rut there is preliminary laboratory evidence of a simultaneous outbreak of
varicella in the same geographic region which will undoubtedly modify these
preliminary results. Since smallpox was eradicated and vaccinia vaccinatio
n terminated in this region, the population of susceptible individuals has
grown. The use of vaccination to protect the population at risk, however, m
ust take into account HIV prevalence and the risk of generalized vaccinia w
hen using vaccinia vaccine in populations where HIV is known to be present.